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Estrogens exert pleiotropic functions in humans, ranging
from neuroprotection and prevention of osteoporosis to cardioprotection and growth of breast tissue (1). These effects are
produced through two members of the nuclear receptor super-
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family, estrogen receptor-␣ (ER-␣)4 and ER-␤ (2). The receptors share distinct structural and functional domains. These
are the A/B regions, which contain a transactivation domain
(AF1), the C region, which corresponds to the DNA-binding
domain, the D region containing the hinge domain, and the E/F
regions in which the ligand binding domain is located (2). Binding of 17␤-estradiol (E2) to ER-␣ elicits effects in target tissues
via the “classic” pathway or by non-genomic signaling through
activation of protein kinase cascades (2, 3). In the classic signaling mechanism, E2 induces a conformational change in ER-␣,
which then dimerizes. The E2-bound receptor translocates to
the nucleus where it binds to DNA at estrogen response elements (EREs) and recruits co-regulatory proteins. These co-activators and co-repressors modulate the transcriptional activation of genes by ER-␣. A substantial body of evidence implicates
perturbation of E2 signaling in cancer initiation, progression,
and response to therapy (2). Although best characterized in
breast cancer, ER also contributes to carcinoma of the endometrium and prostate. A clear understanding of the molecular
mechanism of ER-␣ signaling is required to develop better therapeutic modalities for these neoplasms.
Recent data indicate that numerous proteins influence the
structure and function of ER-␣, stabilize the ER-␣/DNA interaction, and modulate gene expression (4). These proteins are
involved in cell cycle regulation, chromatin remodeling, protein
turnover, and cell migration. Accumulating evidence shows
that a group of ER-␣ modifying proteins participate in cell signaling. For example, the scaffold protein IQGAP1, which integrates diverse signaling pathways (5, 6), binds ER-␣ and modulates its transcriptional function (7).
Another signaling protein that influences ER-␣ is the Ca2⫹
modulator calmodulin (CaM). CaM is a highly conserved protein that contains 148 amino acids. Via direct interactions with
numerous diverse proteins, CaM regulates several cellular
functions including growth, proliferation, and cell cycle progression (8). CaM binds directly to ER-␣, but not to ER-␤ (9,
10), in a Ca2⫹-regulated manner (11, 12). This interaction regulates the degradation of ER-␣ via the ubiquitin-proteasome
4

The abbreviations used are: ER-␣, estrogen receptor-␣; CaM, calmodulin;
ERE, estrogen-response element; CaM-F, full-length calmodulin; CaM-C,
calmodulin C-terminal lobe; CaM-N, calmodulin N-terminal lobe; E2, 17-␤estradiol; hnRNA, heterogeneous nuclear RNA; EGFP, enhanced green fluorescent protein; PR, progesterone receptor; HSQC, heteronuclear single
quantum coherence; NOE, nuclear Overhauser effect.
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Estrogen receptor ␣ (ER-␣) is a nuclear hormone receptor
that controls selected genes, thereby regulating proliferation
and differentiation of target tissues, such as breast. Gene expression controlled by ER-␣ is modulated by Ca2ⴙ via calmodulin (CaM). Here we present the NMR structure of Ca2ⴙ-CaM
bound to two molecules of ER-␣ (residues 287–305). The two
lobes of CaM bind to the same site on two separate ER-␣ molecules (residues 292, 296, 299, 302, and 303), which explains why
CaM binds two molecules of ER-␣ in a 1:2 complex and stabilizes ER-␣ dimerization. Exposed glutamate residues in CaM
(Glu-11, Glu-14, Glu-84, and Glu-87) form salt bridges with key
lysine residues in ER-␣ (Lys-299, Lys-302, and Lys-303), which is
likely to prevent ubiquitination at these sites and inhibit degradation of ER-␣. Transfection of cells with full-length CaM
slightly increased the ability of estrogen to enhance transcriptional activation by ER-␣ of endogenous estrogen-responsive
genes. By contrast, expression of either the N- or C-lobe of CaM
abrogated estrogen-stimulated transcription of the estrogen
responsive genes pS2 and progesterone receptor. These data
suggest that CaM-induced dimerization of ER-␣ is required for
estrogen-stimulated transcriptional activation by the receptor. In light of the critical role of ER-␣ in breast carcinoma,
our data suggest that small molecules that selectively disrupt
the interaction of ER-␣ with CaM may be useful in the therapy of breast carcinoma.

CaM-induced Dimerization of ER-␣

Results
NMR Structure of Full-length CaM Bound to Two Molecules
of ER-␣—Previously we solved NMR structures of individual
CaM lobes (CaM-N and CaM-C) each bound to a peptide fragment of ER-␣ (residues 287–305, called ER(287–305)) (15). The
N-terminal half (CaM-N, amino acids 1–74) and the C-terminal half (CaM-C, amino acids 75–148) of calmodulin each
bound to one ER-␣ with nearly the same affinity as full-length
CaM (CaM-F) binds to two ER-␣ (15). Thus, the two CaM lobes
bind independently to two separate ER-␣ molecules, suggesting
that CaM may stabilize dimerization of ER-␣. In the current
study, we present a NMR structural analysis of full-length CaM
bound to two molecules of ER(287–305). The 1H-15N HSQC
spectrum of 15N-labeled CaM bound to two molecules of
ER(287–305) (Fig. 1A) looks similar to the NMR spectra of
CaM-N (cyan in Fig. 1A) and CaM-C (magenta in Fig. 1A) each
bound to one molecule of ER(287–305). This spectral similarity
demonstrates that in the full-length protein both CaM lobes are
independently folded and each lobe binds independently to a
separate ER-␣ molecule. The constant time 1H-13C HSQC
spectrum of 13C-labeled CaM bound to two molecules of unlabeled ER(287–305) also matches quite well to both spectra of
the individual lobes (Fig. 1B). The agreement of the methyl
chemical shifts in 1H-13C HSQC spectra (of CaM-F versus
CaM-N and CaM-C) demonstrates that the structural environment of side chain methyl groups in the exposed hydrophobic
core of both lobes that contact ER(287–305) must be
unchanged in full-length CaM. Therefore, the structure of the
individual lobes bound to ER-␣ determined previously (15)
must have a similar structure in full-length CaM bound to two
ER-␣ molecules. To further test this hypothesis, we solved the
MARCH 17, 2017 • VOLUME 292 • NUMBER 11

NMR structure of full-length CaM bound to two ER(287–305)
molecules.
An NMR-derived structural model of full-length CaM bound
to two molecules of ER(287–305) is shown in Fig. 2. Threedimensional protein structures derived from the NMR assignments were calculated on the basis of NOE data, chemical shift
analysis, 3JNH␣ spin-spin coupling constants, and residual dipolar coupling restraints as described previously (15) (see “Experimental Procedures”). Table 1 summarizes the structural statistics calculated for the 10 lowest energy conformers.
The main chain structure of the N-lobe in full-length CaM
bound to ER(287–305) looks quite similar to the structure of
CaM-N bound to ER(287–305) (15). The root mean square
deviation is ⬍0.6 Å when comparing the main chain atoms of
the full-length CaM N-lobe versus CaM-N. The EF-hand interhelical angles for the full-length CaM N-lobe (bound to
ER(287–305) are 84° for EF1 and 90° for EF2, which are lower
than those for free CaM (EF1, 103.8° and EF2, 101°). Exposed
hydrophobic side chains in the full-length CaM N-lobe (Met51, Val-55, Ile-63, and Met-72) interact with the aromatic side
chain of Trp-292 from ER(287–305) (Fig. 2B). Also noteworthy
are exposed glutamate side chains in full-length CaM N-lobe
(Glu-11 and Glu-14) that form salt bridges with lysine residues
in ER-␣ (Lys-299 and Lys-303).
The main chain structure of the C-lobe in full-length CaM
bound to ER(287–305) (Fig. 2) looks similar to the structure of
CaM-C bound to ER(287–305) (15). The root mean square
deviation is ⬍0.8 Å when comparing the main chain atoms of
the full-length CaM C-lobe versus CaM-C. The EF-hand interhelical angles for the full-length CaM C-lobe bound to ER-␣
(103 °C for EF3 and 94 °C for EF4) are close to those for free
CaM. Exposed hydrophobic residues in CaM (Ile-100, Leu-105,
Val-108, Met-124, and Ile-125) form close contacts with the
aromatic side chain of Trp-292 from ER(287–305) (Fig. 2C).
Two lysine residues in ER-␣ (Lys-299 and Lys-303) form salt
bridges with Glu-84 and Glu-87 in CaM.
The CaM Lobes Bind ER-␣ in Cell Lysates—Analysis was conducted to determine whether CaM-N and CaM-C could bind
endogenous ER-␣ in a normal cell milieu. To evaluate this interaction, we wanted to transfect cells with the individual lobes of
CaM and examine ER-␣ binding. Although expression of intact
full-length CaM in cells was readily achieved, we encountered
considerable difficulty expressing the isolated lobes of CaM in
mammalian cells. After numerous attempts with several different plasmids that express the N- or C-terminal half of CaM,
we were eventually successful with GFP-tagged constructs. We
generated GFP-tagged constructs of full-length CaM and the
two halves; the N-terminal half, amino acids 1–74, and the
C-terminal half, amino acids 75–148. Transfection of HEK-293
or MCF-7 cells with each plasmid yielded clear, and reproducible, protein expression as detected with anti-GFP antibody
(Figs. 3A, 4C, 5C, and 6C). Each protein migrated to its expected
position on SDS-PAGE.
To examine binding, we transfected GFP-tagged CaM-F,
CaM-N, and CaM-C into HEK-293 cells, isolated the proteins
with GFP-Trap_A agarose, and then incubated them with
MCF-7 cell lysates. GFP-tagged full-length CaM bound to
endogenous ER-␣ in MCF-7 cell lysates (Fig. 3A). These findJOURNAL OF BIOLOGICAL CHEMISTRY
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pathway (13) and is also required for normal transcriptional
function of ER-␣ (14). To gain insight into the molecular mechanism by which CaM produces these effects, we recently conducted structural analysis and solved the NMR structures of the
individual lobes of CaM (N- and C-lobes) each bound to a functional fragment of ER-␣ (residues 287–305) (15). Shortly thereafter, Leclercq and colleagues (16) published a manuscript in
which they analyzed the interaction of CaM with peptides corresponding to amino acid residues 287–311 and 295–311 of
ER-␣. These studies yielded two distinct models to describe the
interaction between CaM and ER-␣ (15, 16). Our data revealed
that one CaM molecule binds two molecules of ER-␣ in a 1:2
complex (15). We generated a model in which each lobe of CaM
is attached to a separate hinge domain of ER-␣, suggesting that
CaM can facilitate dimerization of ER-␣. By contrast, Carlier et
al. (16) put forward a scheme in which the two lobes of CaM
interact allosterically and CaM undergoes a concerted conformational change when binding ER-␣. To reconcile these conflicting models and determine the correct mode of binding, we
analyzed the structure of full-length CaM bound to two ER-␣
peptides. The data presented here reveal that this structure is
identical to the structures of the separate CaM lobes each
bound to ER-␣. Thus, the two ER-␣ binding sites on CaM are
completely independent. In addition, analysis of ER-␣ transcriptional activity in human cells transfected with separate
lobes of CaM provides in vivo evidence that bolsters our model.

CaM-induced Dimerization of ER-␣

ings are congruent with our prior documentation that endogenous ER-␣ co-immunoprecipitates with endogenous untagged
CaM from MCF-7 human breast epithelial cells (11). Consistent with the in vitro data generated with pure CaM-N, CaM-C,
and the fragment of ER-␣ (287–305) (15), we observed that the
individual lobes of CaM could precipitate endogenous ER-␣
from cell lysates (Fig. 3A). Moreover, in keeping with the stoichiometry data, the amount of ER-␣ bound to CaM-F is considerably greater than that bound to CaM-N or CaM-C. No
ER-␣ is present in samples containing GFP alone (Fig. 3A), validating the specificity of the interaction with the CaM constructs. Probing the blots for GFP showed similar amounts of
each CaM construct (Fig. 3A, lower panel). These data reveal
that the N- and C-halves of CaM independently bind ER-␣ in
cell lysates.
To determine whether CaM-N and CaM-C are capable of
binding other targets, we examined IQGAP1, which contains
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four IQ motifs that interact with CaM (17). We tagged
CaM-F, CaM-N, and CaM-C with GST, expressed the proteins in Escherichia coli (Fig. 3B, lower panel) and incubated
each with equal amounts of MCF-7 cell lysate. GST-tagged
full-length CaM bound to IQGAP1 in cell lysates (Fig. 3B).
Similarly, CaM-N and CaM-C each bind to endogenous
IQGAP1. Thus, the individual lobes of CaM can bind to at
least two targets that have different modes of association
with CaM.
Individual Lobes of CaM Abrogate E2-stimulated Transcription by ER-␣—If full-length CaM binds two molecules of ER-␣,
thus promoting receptor dimerization and facilitating ER-␣
transcriptional activity, one would anticipate that the individual lobes of CaM would elicit a different effect. In this
situation, each lobe of CaM would bind to a separate molecule of ER-␣, but the separate CaM lobes would not be able
to induce receptor dimerization and ER-␣ transcriptional
VOLUME 292 • NUMBER 11 • MARCH 17, 2017
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FIGURE 1. NMR spectroscopy of CaM binding to ER(287–305). A, 15N-1H HSQC spectra of 15N-labeled full-length CaM (black), CaM-N (cyan), and CaM-C
(magenta) in the presence of unlabeled ER(287–305). B, constant time 13C-1H HSQC spectra of 13C-labeled full-length CaM (black), CaM-N (cyan), and CaM-C
(magenta) in the presence of unlabeled ER(287–305). The experimental conditions are defined under “Experimental Procedures” and were the same as
described previously (15).

CaM-induced Dimerization of ER-␣

TABLE 1
Structure statistics for NMR structures of CaM bound to ER(287–305)
NMR restraints
Short range NOEs for ER peptides
Dihedral angles
H-bonds
Total intermolecular NOEs
1
DHN RDC
Ramachandran plot
Most favored region (%)
Allowed region (%)
Disallowed region (%)
Root mean squared deviation from average structure (Å)
All backbone atoms

30
79
66
96
76
80.5
18.0
1.5
0.59

activity would therefore not be increased. The strategy we
adopted to test this hypothesis was to transfect cells with the
individual lobes of CaM and examine ER-␣ function.
MARCH 17, 2017 • VOLUME 292 • NUMBER 11

The effect of the CaM constructs on ER-␣ function was evaluated by assessing the ability of ER-␣ to activate selected endogenous estrogen responsive genes. E2 promotes an increase of
pS2 hnRNA in HEK-293 cells that were transfected with ER-␣
(Fig. 4A, left panel). (HEK-293 cells do not contain endogenous
ER-␣ (data not shown).) Transfection of GFP-tagged fulllength CaM slightly enhanced the ability of E2 to stimulate pS2
RNA. By contrast, expression of either CaM-N or CaM-C abrogated the effect of E2 on the transcriptional activation by ER-␣
(Fig. 4A, right panel). To extend these findings, we examined
the effect of CaM on the ability of ER-␣ to activate progesterone
receptor (PR), which is another endogenous estrogen-responsive gene. Analysis showed that either CaM-N or CaM-C
blocked the increase in PR elicited by E2 (Fig. 4B). Western
JOURNAL OF BIOLOGICAL CHEMISTRY
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FIGURE 2. Structures of CaM䡠ER-␣ complexes. A, NMR structure of full-length
CaM (dark blue) bound to two molecules of ER(287–305) (orange). The atomic
coordinates were deposited into the Protein Data Bank (PDB accession no. 5T0X).
Previous NMR structures of CaM-N (2LLO, cyan) and CaM-C (2LLQ, magenta) are
overlaid on the full-length CaM structure for comparison. Bound Ca2⫹ are yellow
spheres. The flexible interdomain linker (residues 74 – 82) forms an extended
main chain conformation depicted by a blue line. B and C, exposed hydrophobic
side chain atoms of CaM N-lobe (highlighted cyan in panel B) and C-lobe (highlighted magenta in panel C) interact with side chain atoms of key ER-␣ residues
(orange) shown as sticks. Hydrophobic side chain atoms in ER-␣ (Trp-292) form
detailed contacts with each lobe of CaM, and basic side chains in ER-␣ (Lys-299
and Lys-303) form salt bridges with Glu-14 (N-lobe) and Glu-84 (C-lobe) of CaM.

FIGURE 3. Binding of the CaM constructs to ER-␣ and IQGAP1. A, HEK-293
cells were transfected with GFP-tagged CaM-F (F), CaM-N (N), or CaM-C (C) or
GFP alone (as control). GFP-tagged proteins were isolated with GFP-Trap_A
agarose as described under “Experimental Procedures,” then incubated with
equal amounts of protein lysate from MCF-7 cells. An aliquot of MCF-7 lysate
that was not incubated with GFP-CaM or GFP was processed in parallel
(Lysate). Proteins were resolved by SDS-PAGE and Western blots were probed
with anti-ER-␣ (upper panel) and anti-GFP (lower panel) antibodies. Data are
representative of 3 independent experiments. B, equal amounts of protein
lysate from MCF-7 cells were incubated with GST-tagged CaM-F (F), CaM-N
(N), or CaM-C (C) or GST alone (control). Complexes were isolated with glutathione-Sepharose. An aliquot of lysate was processed in parallel (Lysate). Proteins were resolved by SDS-PAGE and the gel was cut at ⬃60 kDa. The top part
of the gel was transferred to PVDF, whereas the lower part was stained with
Coomassie Blue (lower panel). PVDF membranes were probed with anti-IQGAP1 antibodies (upper panel). Data are representative of 2 independent
experiments.

CaM-induced Dimerization of ER-␣

blotting of protein lysates confirmed that the cells expressed
equivalent amounts of each CaM construct and had the same
level of ER-␣ (Fig. 4C).
To determine whether the expression of GFP-tagged CaM-N
or CaM-C can interfere with E2 stimulation of endogenous
ER-␣, MCF-7 were transfected with these constructs and transcription of pS2 and PR hnRNA was examined by quantitative
RT-PCR. E2 stimulated transcription of pS2 by ER-␣ in MCF-7
cells transfected with GFP-tagged CaM-F (Fig. 5A). Analogous
to the observations in HEK-293 cells, E2 was unable to increase
pS2 transcription in MCF-7 cells transfected with CaM-N or
CaM-C. Similarly, the ability of E2 to increase PR in MCF-7
cells was abrogated in the presence of CaM-N or CaM-C (Fig.
5B). The level of expression of each CaM construct was equivalent (Fig. 5C).

4618 JOURNAL OF BIOLOGICAL CHEMISTRY

FIGURE 5. Individual lobes of CaM impair E2 stimulation of endogenous
ER-␣ transcription. A and B, MCF-7 cells were transiently transfected with
either GFP-tagged CaM-F, CaM-N, or CaM-C. Cells were cultured in phenol
red-free medium for 24 h, then vehicle (EtOH, blue bars) or 100 nM E2 (red bars)
was added to the medium. After incubation for 6 h, total RNA was isolated and
quantitative RT-PCR analysis was performed to measure pS2 (panel A) or PR
(panel B) hnRNA. The amount of RNA in each sample was corrected for ␤-actin
RNA in the same sample. Vehicle-treated cells were set as 1. The data represent the mean ⫾ S.E. (error bars) of an experiment performed in triplicate. C,
MCF-7 cells, transfected as outlined above, were lysed and equal amounts of
protein lysate were resolved by Western blotting. Blots were probed with
antibodies to ER-␣ (upper panel) and GFP (lower panel). All data are representative of at least 3 independent experiments.

To ascertain whether the individual lobes of CaM could
interfere with the effects of full-length CaM, we co-transfected
full-length CaM with either CaM-N or CaM-C and examined
E2-stimulated transcriptional activation. In HEK-293 cells
transfected with full-length CaM and empty vector, E2 significantly stimulated the transcriptional activation of pS2 RNA
(Fig. 6A). However, when cells were co-transfected with fulllength CaM and CaM-N, E2 was unable to promote transcriptional activation of pS2 RNA. Similarly, transfecting CaM-C
together with full-length CaM into cells completely prevented
VOLUME 292 • NUMBER 11 • MARCH 17, 2017
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FIGURE 4. CaM alters ER-␣ function. A, HEK-293 cells were transiently transfected with both ER-␣ and GFP-tagged CaM-F, CaM-N, CaM-C, or pEGFP (Vector). Cells were cultured in phenol red-free medium for 24 h, then vehicle
(EtOH, blue bars) or 100 nM E2 (red bars) was added to the medium. After
incubation for 6 h, total RNA was isolated and quantitative RT-PCR analysis
was performed to measure pS2 hnRNA. The amount of RNA in each sample
was corrected for ␤-actin RNA in the same sample. Vehicle-treated cells were
set as 1. The data represent the mean ⫾ S.E. (error bars) of two independent
experiments for vector and CaM-F (left panel) or three or four independent
experiments for CaM-F, CaM-N, and CaM-C (right panel). Each condition was
measured in triplicate. B, HEK-293 cells were transiently transfected with both
ER-␣ and either pEGFP (Vector) or the GFP-tagged CaM plasmids. Following
cell culture and E2 stimulation, performed as described for panel A, PR hnRNA
was measured by quantitative RT-PCR. Samples were analyzed as described
for pS2. The data represent the mean ⫾ S.E. (error bars) of two independent
experiments for vector and CaM-F (left panel) or three or four independent
experiments for CaM-F, CaM-N, and CaM-C (right panel). Each condition was
measured in triplicate. *, p ⬍ 0.05; **, p ⬍ 0.01. C, cells, transfected as outlined
above, were lysed and equal amounts of protein lysate were resolved by
Western blotting. Blots were probed with antibodies to ER-␣ (upper panel)
and GFP (lower panel). A representative experiment of 2 is shown.

CaM-induced Dimerization of ER-␣
ER-␣ and the CaM constructs (Fig. 6C). Collectively these data
indicate that the separate lobes of CaM are able to bind to ER-␣,
but they are unable to induce dimerization and promote activation of the receptor. It is noteworthy that binding of a single
lobe of CaM, either the N- or C-lobe, to ER-␣ completely prevents E2 from stimulating transcriptional activation of the target genes we investigated.

E2 from enhancing transcriptional activation of pS2 RNA
(Fig. 6A). Essentially identical results were observed with PR.
Expression of either CaM-N or CaM-C with full-length CaM
abrogated the transcriptional activation of PR induced by E2
(Fig. 6B). These findings suggest that the individual lobes of
CaM competitively inhibit full-length CaM. Western blotting
of cell lysates verified the expression of equivalent levels of
MARCH 17, 2017 • VOLUME 292 • NUMBER 11

JOURNAL OF BIOLOGICAL CHEMISTRY

4619

Downloaded from http://www.jbc.org/ by guest on October 2, 2019

FIGURE 6. Individual lobes of CaM abrogate E2-stimulated transcriptional activation by ER-␣. A, HEK-293 cells were transiently transfected with
both ER-␣ and pEGFP-CaM-F as well as pEGFP (vector), pEGFP-CaM-N, or
pEGFP-CaM-C. Cells were cultured in phenol red-free medium for 24 h, then
vehicle (EtOH, blue bars) or 100 nM E2 (red bars) was added to the medium.
After incubation for 6 h, total RNA was isolated and quantitative RT-PCR analysis was performed to measure pS2 hnRNA. The amount of RNA in each sample was corrected for ␤-actin RNA in the same sample. Vehicle-treated cells
were set as 1. The data represent the mean ⫾ S.E. (error bars) of six independent experiments, each performed in triplicate. B, HEK-293 cells were transfected and stimulated with E2 as described for panel A. PR hnRNA was measured by quantitative RT-PCR. Samples were analyzed as described for pS2.
The data represent the mean ⫾ S.E. (error bars) of six independent experiments, each performed in triplicate. C, cells, transfected as outlined above,
were lysed and equal amounts of protein lysate were resolved by Western
blotting. Blots were probed with antibodies to ER-␣ (upper panel) and GFP
(lower panel). A representative experiment of 4 is shown. **, p ⬍ 0.005.

Discussion
Previously, we solved the NMR structures of individual CaM
lobes (CaM-N and CaM-C) each of which binds to the same site
on ER-␣ (15). We showed that full-length CaM binds to two
ER-␣ molecules, whereas CaM-N and CaM-C each binds to
only one (15). On the basis of this earlier structural analysis, we
proposed that each lobe of CaM binds to a separate ER-␣ molecule. In the current study, we now present the structure of
full-length CaM bound to two ER-␣ peptides (Fig. 2). The structure reveals that each CaM lobe makes contact with the same
residues of ER-␣ (residues 292, 299, and 303 in Fig. 2B). Furthermore, the structure of both lobes in full-length CaM
(bound to two ER-␣) looks identical to the previous structures
of the individual lobes each bound to a single ER-␣ peptide (15).
This structural independence of the two CaM lobes is consistent with our binding studies (15) that indicate each CaM lobe
binds to ER-␣ with nearly the same binding affinity as fulllength CaM. Finally, the structure of full-length CaM bound to
two molecules of ER-␣ indicates a lack of structural contacts
between the CaM lobes, which argues against allosteric conformational changes suggested by Carlier et al. (16). We conclude
that one molecule of CaM connects two molecules of ER-␣,
which stabilizes its dimer structure and promotes transcriptional activation.
Our in vivo experiments provide biological data to support
the model derived from the structural analysis. Prior work from
our laboratory (11) and others (10, 12, 18), established that CaM
interacts with ER-␣ in vitro and in cells. Binding of CaM modulates both ER-␣ degradation (10, 11, 13) and E2-stimulated
transcriptional activity of ER-␣ (14). Interestingly, CaM is
required for the formation of the ER-␣䡠ERE complex and for
activation of an estrogen responsive promotor (19). We previously generated an ER-␣ construct in which Ile-298 and Lys299 are mutated, rendering the receptor unable to bind CaM
(14). E2 failed to stimulate transcriptional activation of this
mutant ER-␣. Moreover, blocking CaM function in the nucleus
of MCF-7 cells by transfecting a targeted specific CaM inhibitor
peptide abrogated E2-induced transcriptional activation (9).
Collectively, these data strongly suggest that an interaction
between CaM and ER-␣ in the nucleus is required for E2 to
stimulate transcriptional activation.
Consistent with these prior observations, we show here that
overexpression of full-length CaM slightly, albeit not significantly, enhanced by 25% E2-induced transcriptional activation
of two endogenous estrogen-responsive genes, namely pS2 and
PR. The relatively small increase in E2-induced transcriptional
activation is most likely due to the high concentrations of
endogenous CaM in cells, which is 10⫺6 to 10⫺5 M, with even
higher concentrations in rapidly growing cells (8). By contrast,
expression of the separate lobes of CaM in cells abrogated the

CaM-induced Dimerization of ER-␣
TABLE 2
Antibodies used in this study

FIGURE 7. Model of the regulation of ER-␣ dimerization and transcription
by CaM. The N- and C-lobes of CaM are shown in pale blue (CaM-N) and pink
(CaM-C), respectively. Estrogen (E2) induces dimerization of ER-␣. Full-length
CaM (CaM-F) promotes ER-␣ dimerization independently of E2. In contrast,
the individual lobes of CaM block ER-␣ dimerization, thereby preventing
E2-stimulated transcriptional activation by ER-␣. Both E2 and Ca2⫹/CaM are
required for maximal activation of transcription.
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Reference

ER-␣
ER-␣
Calmodulin
GFP
GFP
Myc
IQGAP1

Santa Cruz sc-543
Cell Signaling Technology 8644
Mouse monoclonal (39)
Santa Cruz sc-8334
Santa Cruz sc-9996
Millipore 06–549
Rabbit antiserum (28)

Dilution for
immunoblots
1:1000
1:1000
1:1000
1:1000
1:1000
1:1000
1:1000

(21). Antagonism of ER-␣ with tamoxifen is the most widely
used treatment for patients with breast carcinoma. Our structure and functional data suggest that altering the association of
CaM with ER-␣ is a conceptually appealing therapeutic option.
Consistent with this premise, published studies reveal that
CaM antagonists attenuate the growth of breast cancer cell
lines (22–24) and enhance antiestrogen therapy (25–27). It is
possible that development of specifically targeted small molecules that selectively disrupt the CaM/ER-␣ interaction may be
useful in the treatment of breast carcinoma and other ER-␣-dependent malignancies.

Experimental Procedures
Materials—HEK-293 cells and MCF-7 breast epithelial cells
were obtained from the American Type Culture Collection. All
reagents for tissue culture were bought from Invitrogen. PVDF
membranes were purchased from Millipore Corporation. Antibodies used in this study are listed in Table 2. Blocking buffer
(927-50000) and infrared dye-conjugated (IRDye) antibodies,
both goat anti-mouse IRDye 680LT (926 – 68020) and goat
anti-rabbit IRDye 800CW (926 –32211) were obtained from
LI-COR Biosciences.
Construction of GFP-CaM and GST-CaM—The PCR products of full-length CaM (CaM-F), the N-terminal half (CaM-N,
amino acids 1–74), and the C-terminal half (CaM-C, amino
acids 75–148) of calmodulin were made using pDONR223CaM1 as template. Primers were as follows: for CaM-F, forward
primer, 5⬘-CGGGATCCGCTGATCAGCTGACCGAAGAACAG-3⬘ and reverse primer, 5⬘-GCTCTAGACTCGAGTCATTTTGCAGTCATCATCTGTACGAATTC-3⬘; for CaM-N,
forward primer, 5⬘-CGGGATCCGCTGATCAGCTGACCGAAGAACAG-3⬘ and reverse primer, 5⬘-CCGGAATTCTCTAGATCAATCTTTCATTTTTCTAGCCATCATAG-3⬘; and for CaM-C, forward primer, 5⬘-CGGGATCCACAGATAGTGAAGAAGAAATCCG-3⬘ and reverse primer,
5⬘-GCTCTAGACTCGAGTCATTTTGCAGTCATCATCTGTACGAATTC-3⬘. The PCR products of each CaM construct
were digested with BamHI and XhoI. To generate GFP-CaM,
PCR products were inserted into pEGFP-C1 at BglII and SalI
sites. GST-CaM constructs were generated by inserting PCR
products into pGEX-4T-1 at BamHI and XhoI sites. The
sequences of all plasmids were verified by DNA sequencing.
Plasmids were purified with QIAprep Spin Mini Prep Kit
(Qiagen).
Cell Culture and Transfection—Cells were grown in DMEM
supplemented with 10% FBS. Cells were transfected using Lipofectamine 2000 (Invitrogen) according to the manufacturer’s
instructions.
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ability of E2 to stimulate ER-␣ transcriptional activity. A model
illustrates how CaM regulates dimerization and activation of
ER-␣ (Fig. 7). E2 binding induces dimerization of ER-␣ and
translocation to the nucleus. Association of Ca2⫹/CaM with the
E2-bound ER-␣ enables the receptor to activate transcription of
target genes (Fig. 7). Note that CaM can stimulate ER-␣
dimerization in the absence of E2. When ER-␣ is bound to only
one lobe of CaM instead of the full-length protein, CaM-induced dimerization of ER-␣ cannot occur and E2 is unable to
promote transcription. Thus, binding of both E2 and CaM to
ER-␣ is required for it to maximally activate transcription
(Fig. 7).
The molecular mechanism by which the individual lobes of
CaM abrogate E2-stimulated transcriptional activation by
ER-␣ is unknown. There are several possible explanations.
First, binding of CaM-N or CaM-C to ER-␣ may prevent receptor dimerization, which is necessary for transcriptional activation (2). The NMR structural data presented in this article
strongly support this mechanism. Second, binding to one lobe
of CaM may sterically block the interaction of ER-␣ with coregulatory proteins, particularly co-activators, which modulate
transcriptional activation (20). Third, the ER-␣䡠CaM-N or
ER-␣䡠CaM-C complex may bind co-repressors rather than the
co-activators, which bind to ER-␣䡠CaM (full-length). It is
known that the shape of the ligand䡠ER-␣ complex influences
the specific co-regulators that are recruited (2). The components of the complex influence receptor activity, which activates or represses gene transcription. Fourth, ER-␣ may be
titrated away from other co-regulators by the isolated CaM
lobes. Fifth, the ER-␣䡠CaM-N or ER-␣䡠CaM-C complexes may
be unable to translocate to the nucleus where transcription is
activated. These mechanisms are not mutually exclusive and
more than one may account for our data.
Regardless of the molecular mechanism, our observations
elucidate the structure and biological function of the interaction between ER-␣ and CaM. It is estimated that 70% of breast
malignancies are ER-␣ positive and therefore agents that suppress receptor function or E2 synthesis are used for therapy
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cDNA Reverse Transcriptase kit (Applied Biosystems) according to the manufacturer’s instructions. RT-PCR was performed
on a StepOnePlus Real Time PCR system (Applied Biosystems)
using SYBR Green PCR master mix (Applied Biosystems) and
200 nM forward and reverse primers. The primers used were:
for PR, forward primer, 5⬘-CCTCGGACACCTTGCCTGAA3⬘, reverse primer, 5⬘-CGCCAACAGAGTGTCCAAGAC-3⬘;
for pS2, forward primer, 5⬘-TTGGAGAAGGAAGCTGGATGG-3⬘, reverse primer, 5⬘-ACCACAATTCTGTCTTTCACGG-3⬘; and for ␤-actin, forward primer, 5⬘-TGCGTGACATTAAGGAGAAG-3⬘, reverse primer, 5⬘-GCTCGTAGCTCTTCTCCA-3⬘. RT-PCR enzyme activation was initiated for 10 min at 95 °C, then amplified by 40 cycles (15 s at
95 °C and 1 min at 60 °C). All samples were assayed in triplicate
and ␤-actin was used as an internal control. Results were analyzed using the ⌬⌬CT method with StepOnePlus software
(Applied Biosystems). RT-PCR with MCF-7 cells was performed essentially as described for HEK-293 cells, except the
transfection with pcDNA3-myc-ER-␣ was omitted as MCF-7
cells have endogenous ER-␣.
NMR Sample Preparation—NMR samples of isotopically
labeled CaM bound to ER(287–305) were prepared as
described previously (15). Purified CaM (3.5 mg) was initially
dissolved in 10 ml of NMR buffer (20 mM Tris-d11, 5 mM CaCl2,
50 mM NaCl, 8% D2O, pH 7.0) and then added to 2 eq of
ER(287–305). The CaM䡠ER complex was incubated at room
temperature for 1 h, and concentrated to 0.4 ml using Amicon
Ultra Centrifugal Filters Ultracel-3K (Millipore, UFC900324, 3
kDa cut-off).
NMR Spectroscopy—All NMR experiments were carried out
at 310 K and performed using Bruker Avance III 800 MHz spectrometer equipped with a four-channel interface and tripleresonance cryoprobe (TCI). Two-dimensional NMR experiments, 15N-1H HSQC (and constant-time 13C-1H HSQC)
spectra were recorded on a sample of 15N-labeled (13C-labeled)
CaM in the presence of unlabeled ER(287–305). All three-dimensional NMR experiments for assigning backbone and side
chain resonances were recorded on a double labeled sample
(15N,13C-labeled CaM bound to unlabeled ER(287–305) as
described previously (15). NMR distance restraints were
obtained as described (15). NMR data were processed using
NMRPipe (30) and analyzed with SPARKY (T. D. Goddard and
D. G. Kneller, University of California at San Francisco).
Structure Calculation—The NMR structure of full-length
CaM bound to ER(287–305) was calculated using NMR-derived distance restraints and residual dipolar couplings as
described previously (15, 31–33). The structure of ER(287–
305) bound to full-length CaM was verified to form an ␣-helix
based on NOE distance restraints (HN-HN connectivity), chemical shift index (34), and circular dichroism analysis as
described previously (15). The NMR-derived structures of CaM
and ER(287–305) were then used as input for molecular docking within HADDOCK (35–38) using intermolecular NOE
restraints and residual dipolar coupling data as described previously (15). The structure of ER(287–305) in the docking calculation was set as full flexible, and side chain atoms of CaM
that exhibited intermolecular NOEs with ER(287–305) were
allowed to move during simulated annealing. The final strucJOURNAL OF BIOLOGICAL CHEMISTRY
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Preparation of GST Fusion Proteins—GST-CaM-F, GSTCaM-N, and GST-CaM-C were expressed in E. coli and purified by glutathione-Sepharose chromatography, essentially as
described previously (28). All fusion proteins migrated to the
expected position on SDS-PAGE. Proteins were at least 90%
pure by Coomassie staining.
Binding Analysis—The binding of the CaM constructs to
endogenous ER-␣ in MCF-7 lysates was evaluated. First, GFPtagged CaM-F, CaM-N, or CaM-C (or GFP alone) were transfected into HEK-293 cells. Cells were cultured at 37 °C for 3
days, then lysed with 500 l of Buffer A (50 mM Tris-HCl, pH
7.4, 150 mM NaCl, and 1% Triton X-100) containing 1 mM
EGTA, 1⫻ Protease & Phosphatase Inhibitor Mixture (Thermo
Scientific), and 1 mM PMSF. GFP was immunoprecipitated
with GFP-Trap_A (anti-GFP VHH conjugated to agarose,
ChromoTek) for 3 h at 4 °C, then washed 3 times with Buffer A
containing 1 mM EGTA. MCF-7 cells were lysed with Buffer A
containing 1 mM CaCl2, 1 mM PMSF, and 1⫻ Protease & Phosphatase Inhibit Mixture. Equal amounts of MCF-7 protein
lysate were incubated for 3 h at 4 °C with the GFP-tagged proteins on agarose beads. After 5 washes with Buffer A containing
1 mM CaCl2, samples were resolved by SDS-PAGE (29) and
transferred to PVDF. The membrane was blocked with Blocking Buffer (LI-COR) for 1 h at 22 °C, probed overnight at 4 °C
with anti-ER-␣ polyclonal antibodies, then incubated for 1 h
with IRDye-conjugated anti-rabbit antibody. Antigen-antibody
complexes were detected using the Odyssey Imaging System
(LI-COR). GFP-tagged proteins were detected by probing the
membrane with anti-GFP monoclonal antibody, followed by
IRDye-conjugated anti-mouse antibody and detected with the
Odyssey Imaging System.
Binding of CaM-F, CaM-N, and CaM-C to endogenous
IQGAP1 was also performed. MCF-7 cells were lysed with 500
l of Buffer A containing 2 mM EDTA, 1⫻ Protease & Phosphatase Inhibitor Mixture, and 1 mM PMSF, then pre-cleared by
rotating for 1 h at 4 °C with glutathione-Sepharose beads. Equal
amounts of protein lysate were incubated with 40 l of GSTCaM-F, GST-CaM-N, GST-CaM-C, or GST (control). All GST
fusion proteins were bound to glutathione-Sepharose beads
prior to adding lysate. After rotating at 4 °C for 3 h, samples
were washed 5 times with Buffer A and resolved by SDS-PAGE
(29). The gel was cut slightly above the 50-kDa molecular mass
marker into two pieces. The lower portion of the gel was stained
with Coomassie Blue. The upper portion of the gel was transferred to PVDF and processed essentially as described for ER-␣,
except the blots were probed with anti-IQGAP1 antibodies.
Quantitative RT-PCR—HEK-293 cells were cultured in phenol red-free medium with 10% charcoal-stripped fetal bovine
serum (FBS), and transfected with pcDNA3-myc-ER-␣ and
pEGFP-CaM-F, pEGFP-CaM-N, pEGFP-CaM-C, or pEGFP
(vector). Where indicated, cells were transfected with both
pcDNA3-myc-ER-␣ and pEGFP-CaM-F, as well as pEGFPCaM-N, pEGFP-CaM-C, or pEGFP. The next day, the medium
was replaced with fresh FBS-free medium. After 2 days, vehicle
(EtOH) or E2 (to obtain a final concentration of 100 nM) were
added to the medium. Following a 6-h incubation, total RNA
was isolated from the cells using TRIzol (Invitrogen). 2 g of
RNA was reverse transcribed to cDNA using a High Capacity

CaM-induced Dimerization of ER-␣
tures were further refined by including a final water refinement
step.
Miscellaneous Methods—Statistical analysis was performed
by Student’s t test with Prism 6 (GraphPad). Protein concentrations were measured with the DC Protein Assay (Bio-Rad).
Author Contributions—J. B. A. and D. B. S. designed the study. Z. L.,
Y. Z., and A. C. H. conducted experiments. Z. L., Y. Z., A. C. H.,
J. B. A., and D. B. S. analyzed data. J. B. A. and D. B. S. wrote the manuscript. All authors reviewed the results and approved the final version of the manuscript.
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